Diminished Hepatic Gluconeogenesis via Defects in TCA Cycle Flux in PPARγ Coactivator- 1α (PGC-1α)-Deficient Mice

نویسندگان

  • Shawn C. Burgess
  • Teresa C. Leone
  • Adam R. Wende
  • Michelle A. Croce
  • Zhouji Chen
  • A. Dean Sherry
  • Craig R. Malloy
  • Brian N. Finck
چکیده

The peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α) is a highly-inducible transcriptional coactivator implicated in the coordinate regulation of genes encoding enzymes involved in hepatic fatty acid oxidation, oxidative phosphorylation, and gluconeogenesis. The present study sought to assess the effects of chronic PGC-1α deficiency on metabolic flux through the hepatic gluconeogenic, fatty acid oxidation, and TCA cycle pathways. To this end, hepatic metabolism was assessed in wild-type (WT) and PGC-1α mice using isotopomer-based NMR with complimentary gene expression analyses. Hepatic glucose production was diminished in PGC-1α livers coincident with reduced gluconeogenic flux from phosphoenolpyruvate. Surprisingly, the expression of PGC-1α target genes involved in gluconeogenesis was unaltered in PGC-1α compared to wild-type mice under fed and fasted conditions. Flux through TCA cycle and mitochondrial fatty acid β-oxidation pathways was also diminished in PGC-1α livers. The expression of multiple genes encoding TCA cycle and oxidative phosphorylation enzymes was significantly depressed in PGC-1α mice and was activated by PGC-1α overexpression in liver in wild-type mice. Collectively, these findings suggest that chronic whole-animal PGC-1α deficiency results in defects in hepatic glucose production that are secondary to diminished fatty acid β-oxidation and TCA cycle flux rather than abnormalities in gluconeogenic enzyme gene expression per se.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism

OBJECTIVE Peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1α (PGC-1α) promotes hepatic gluconeogenesis by activating HNF4α and FoxO1. PGC-1α expression in the liver is highly elevated in obese and diabetic conditions, leading to increased hepatic glucose production. We previously showed that the spliced form of X-box binding protein 1 (XBP1s) suppresses FoxO1 activity and hepat...

متن کامل

Transcriptional coactivator NT‐PGC‐1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis

The transcriptional coactivator PGC-1α plays a central role in hepatic gluconeogenesis. We previously reported that alternative splicing of the PGC-1α gene produces an additional transcript encoding the truncated protein NT-PGC-1α NT-PGC-1α is co-expressed with PGC-1α and highly induced by fasting in the liver. NT-PGC-1α regulates tissue-specific metabolism, but its role in the liver has not be...

متن کامل

Morin, a plant derived flavonoid, modulates the expression of peroxisome proliferator-activated receptor-γ coactivator-1α mediated by AMPK pathway in hepatic stellate cells.

Morin exerts inhibitory effects on hepatic stellate cell (HSC) stimulation which is considered important step for fibrogenesis in liver. These morin-induced inhibitory effects are mediated through enhancement in the expression levels of peroxisome proliferator-activated receptor-γ (PPARγ). PPARγ plays a critical role in inhibition of HSC stimulation. Peroxisome proliferator-activated receptor-γ...

متن کامل

Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.

The role of a glucagon/cAMP-dependent protein kinase-inducible coactivator PGC-1α signaling pathway is well characterized in hepatic gluconeogenesis. However, an opposing protein kinase B (PKB)/Akt-inducible corepressor signaling pathway is unknown. A previous report has demonstrated that small heterodimer partner-interacting leucine zipper protein (SMILE) regulates the nuclear receptors and tr...

متن کامل

ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis

BACKGROUND Atherosclerosis is a chronic inflammatory disease that evolves from the interaction of activated endothelial cells, macrophages, lymphocytes and modified lipoproteins (LDLs). In the last years many molecules with crucial metabolic functions have been shown to prevent important steps in the progression of atherogenesis, including peroxisome proliferator activated receptors (PPARs) and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006